Regulatory affairs

Patheon slashes losses in Q3

Patheon slashes losses in Q3

By Phil Taylor

Canada’s Patheon put in another quarter of robust revenues growth in its third quarter, which coupled with cost-reduction measures helped the firm trim its net loss to $14.7m, down 75 per cent on a year ago.

FDA embraces outsourcing

FDA embraces outsourcing

By Kirsty Barnes

The US Food and Drug Administration (FDA) is following the growing
pharma industry trend by embracing outsourcing as part of a
cost-saving drive - a move that is attracting strong opposition.